RT Journal Article
T1 European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS).
A1 Egea, Javier
A1 Fabregat, Isabel
A1 Frapart, Yves M
A1 Ghezzi, Pietro
A1 Görlach, Agnes
A1 Kietzmann, Thomas
A1 Kubaichuk, Kateryna
A1 Knaus, Ulla G
A1 Lopez, Manuela G
A1 Olaso-Gonzalez, Gloria
A1 Petry, Andreas
A1 Schulz, Rainer
A1 Vina, Jose
A1 Winyard, Paul
A1 Abbas, Kahina
A1 Ademowo, Opeyemi S
A1 Afonso, Catarina B
A1 Andreadou, Ioanna
A1 Antelmann, Haike
A1 Antunes, Fernando
A1 Aslan, Mutay
A1 Bachschmid, Markus M
A1 Barbosa, Rui M
A1 Belousov, Vsevolod
A1 Berndt, Carsten
A1 Bernlohr, David
A1 Bertrán, Esther
A1 Bindoli, Alberto
A1 Bottari, Serge P
A1 Brito, Paula M
A1 Carrara, Guia
A1 Casas, Ana I
A1 Chatzi, Afroditi
A1 Chondrogianni, Niki
A1 Conrad, Marcus
A1 Cooke, Marcus S
A1 Costa, João G
A1 Cuadrado, Antonio
A1 My-Chan Dang, Pham
A1 De Smet, Barbara
A1 Debelec-Butuner, Bilge
A1 Dias, Irundika H K
A1 Dunn, Joe Dan
A1 Edson, Amanda J
A1 El Assar, Mariam
A1 El-Benna, Jamel
A1 Ferdinandy, Péter
A1 Fernandes, Ana S
A1 Fladmark, Kari E
A1 Förstermann, Ulrich
A1 Giniatullin, Rashid
A1 Giricz, Zoltán
A1 Görbe, Anikó
A1 Griffiths, Helen
A1 Hampl, Vaclav
A1 Hanf, Alina
A1 Herget, Jan
A1 Hernansanz-Agustín, Pablo
A1 Hillion, Melanie
A1 Huang, Jingjing
A1 Ilikay, Serap
A1 Jansen-Dürr, Pidder
A1 Jaquet, Vincent
A1 Joles, Jaap A
A1 Kalyanaraman, Balaraman
A1 Kaminskyy, Danylo
A1 Karbaschi, Mahsa
A1 Kleanthous, Marina
A1 Klotz, Lars-Oliver
A1 Korac, Bato
A1 Korkmaz, Kemal Sami
A1 Koziel, Rafal
A1 Kračun, Damir
A1 Krause, Karl-Heinz
A1 Křen, Vladimír
A1 Krieg, Thomas
A1 Laranjinha, João
A1 Lazou, Antigone
A1 Li, Huige
A1 Martínez-Ruiz, Antonio
A1 Matsui, Reiko
A1 McBean, Gethin J
A1 Meredith, Stuart P
A1 Messens, Joris
A1 Miguel, Verónica
A1 Mikhed, Yuliya
A1 Milisav, Irina
A1 Milković, Lidija
A1 Miranda-Vizuete, Antonio
A1 Mojović, Miloš
A1 Monsalve, María
A1 Mouthuy, Pierre-Alexis
A1 Mulvey, John
A1 Münzel, Thomas
A1 Muzykantov, Vladimir
A1 Nguyen, Isabel T N
A1 Oelze, Matthias
A1 Oliveira, Nuno G
A1 Palmeira, Carlos M
A1 Papaevgeniou, Nikoletta
A1 Pavićević, Aleksandra
A1 Pedre, Brandán
A1 Peyrot, Fabienne
A1 Phylactides, Marios
A1 Pircalabioru, Gratiela G
A1 Pitt, Andrew R
A1 Poulsen, Henrik E
A1 Prieto, Ignacio
A1 Rigobello, Maria Pia
A1 Robledinos-Antón, Natalia
A1 Rodríguez-Mañas, Leocadio
A1 Rolo, Anabela P
A1 Rousset, Francis
A1 Ruskovska, Tatjana
A1 Saraiva, Nuno
A1 Sasson, Shlomo
A1 Schröder, Katrin
A1 Semen, Khrystyna
A1 Seredenina, Tamara
A1 Shakirzyanova, Anastasia
A1 Smith, Geoffrey L
A1 Soldati, Thierry
A1 Sousa, Bebiana C
A1 Spickett, Corinne M
A1 Stancic, Ana
A1 Stasia, Marie José
A1 Steinbrenner, Holger
A1 Stepanić, Višnja
A1 Steven, Sebastian
A1 Tokatlidis, Kostas
A1 Tuncay, Erkan
A1 Turan, Belma
A1 Ursini, Fulvio
A1 Vacek, Jan
A1 Vajnerova, Olga
A1 Valentová, Kateřina
A1 Van Breusegem, Frank
A1 Varisli, Lokman
A1 Veal, Elizabeth A
A1 Yalçın, A Suha
A1 Yelisyeyeva, Olha
A1 Žarković, Neven
A1 Zatloukalová, Martina
A1 Zielonka, Jacek
A1 Touyz, Rhian M
A1 Papapetropoulos, Andreas
A1 Grune, Tilman
A1 Lamas, Santiago
A1 Schmidt, Harald H H W
A1 Di Lisa, Fabio
A1 Daiber, Andreas
K1 Antioxidants
K1 Oxidative stress
K1 Reactive nitrogen species
K1 Reactive oxygen species
K1 Redox signaling
K1 Redox therapeutics
AB The European Cooperation in Science and Technology (COST) provides an ideal framework to establish multi-disciplinary research networks. COST Action BM1203 (EU-ROS) represents a consortium of researchers from different disciplines who are dedicated to providing new insights and tools for better understanding redox biology and medicine and, in the long run, to finding new therapeutic strategies to target dysregulated redox processes in various diseases. This report highlights the major achievements of EU-ROS as well as research updates and new perspectives arising from its members. The EU-ROS consortium comprised more than 140 active members who worked together for four years on the topics briefly described below. The formation of reactive oxygen and nitrogen species (RONS) is an established hallmark of our aerobic environment and metabolism but RONS also act as messengers via redox regulation of essential cellular processes. The fact that many diseases have been found to be associated with oxidative stress established the theory of oxidative stress as a trigger of diseases that can be corrected by antioxidant therapy. However, while experimental studies support this thesis, clinical studies still generate controversial results, due to complex pathophysiology of oxidative stress in humans. For future improvement of antioxidant therapy and better understanding of redox-associated disease progression detailed knowledge on the sources and targets of RONS formation and discrimination of their detrimental or beneficial roles is required. In order to advance this important area of biology and medicine, highly synergistic approaches combining a variety of diverse and contrasting disciplines are needed.
YR 2017
FD 2017-05-18
LK http://hdl.handle.net/10668/11268
UL http://hdl.handle.net/10668/11268
LA en
DS RISalud
RD Apr 6, 2025